Fred Knoll has led Knoll Capital Management since 1987, and he personally manages Knoll Capital Fund I and Knoll Capital Fund II. Fred Knoll had previously worked with Telos Corporation, General American Investors, Murray Johnstone, and Robert Fleming. He studied at M.I.T. and got his M.B.A. from Columbia University, and his fund focuses on technology stocks.
| Fund Name: | Knoll Capital Management |
| Manager | Fred Knoll |
| Portfolio Value | $159,335,000 |
| Change This QTR | +0.88% |
| No. | Security | Ticker | Shares | Value (x$1000) | Activity | % Port | History |
|---|---|---|---|---|---|---|---|
| 1. | BHVN | 900,844 | $106,813 | +1% | 67.03% | ||
| 2. | ENTX | 2,484,275 | $7,130 | 4.47% | |||
| 3. | Eiger Biopharmaceuticals Inc | 694,232 | $5,762 | 3.61% | |||
| 4. | ORGS | 1,316,364 | $4,568 | 2.86% | |||
| 5. | ALDX | 759,405 | $3,376 | 2.11% |
| Symbol | Company | Filed By | Filing Date | Filing |
|---|---|---|---|---|
| 2021-06-14 | ||||
| 2021-02-16 | ||||
| 2020-08-14 | ||||
| 2020-02-14 | ||||
| 2019-02-14 |
